Is direct stenting an effective therapy for long-term outcome? Results of the randomized bet study  by Carrie, Didier et al.
24A ABSTRACTS - ACCIS2002 (Angiography & lnterventional Cardiology) JACC March 6,2002 
(12 pts). Group 2: FFRti.75 (44 pts). Results: In pts with reduced FFR (group 1) 
LAminr4.0 mm2 was obtained in 3 pts (25%). Moreover, LAminc4.0 mm’was present in 
16 pts (38%) despite of FFRa0.75 (group 2). The comparison of QCA, FFR and ICUS 
parameters between the two groups is shown in table. Conclusions: ICUS assessment of 
the minimal luminal cross-sectional area has only a limited value in determining the clini- 
cal importance of intermediate coronary lesion. Other factors, such as lesion length may 
also influence functional severity of intermediate coronary lesion. 
Ref.DacA L&A MLDacn D%XA FFR LAmintcus LLICUS 
Group1 3.02Y~O.54 18.3i5.8 1.5Mo.17 49.7f7.0 0.67fo.06 3.20M.45 19.5i7.14 
Group2 3.06iO.38 11.3zk3.9 1.48M.27 51.8f7.8 0.85fo.05 3.74il.01 11.2?5.13 
P= NS 0.018 NS NS 0.0027 0.042 0.0017 
1077-26 Pulse Transmisston Coefficient: A Novel Nonhyperemic 
Index for Physiologic Assessment of Procedural 
Success Following Percutaneous Coronary 
Interventions 
Dsyid&&, Stuart T. Higano. Marvin J. Slepian, Hylton I. Miller, Morton J. Kern, David 
R. Holmes, Jr., Amir Lerman, Mayo Clinic Foundation, Rochester, Minnesota, Saint Louis 
University, Saint Louis, Missouri. 
Background: Coronary lesions may impair the transmission of pressure waves across a 
stenosis, potentially acting as a low-pass filter. The pulse transmission coefficient (PTC) 
is a novel non-hyperemic parameter that calculates the transmission of high frequency 
components of the pressure signal through a stenosis. Thus, it may reflect the severity of 
the coronary artery stenosis, This study was designed to study the change of PTC as 
compared to fractional flow reserve (FFR), following percutaneous coronary intervention 
(PCI). 
Methods: Pressure signals were obtained by pressure guidewire in 27 lesions (27 pts.) 
pre and post PCI, and were analyzed with a new algorithm (Florence Medical Ltd.) that 
identifies the high frequency component in the pressure signal. The PTC was calculated 
as the ratio between distal and proximal high frequency components of the pressure 
waveform across the lesion. FFR measurements were assessed with intracoronary ade- 
nosine. 
Results: There was a significant increase in PTC following PCI (0.12iO.03 at baseline to 
0.95M.01 post PCI; p<O.OOl; Figure). Comparable changes were observed for FFR 
(0.57+0.03 at baseline to 0.91M.01 post PCI; p<O.OOl). 
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Conclusions: PTC is a novel non-hyperemic parameter for physiologic assessment of 
coronary artery stenoses. Similarly to FFR. PTC is significantly increased following PCI. 
Thus, It may serve as an adjunct index for the functional assessment of procedural suc- 
cess following PCI, especially in patients with impaired maximal hyperemia. 
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1076-l 1 Lack of Benefit From Routine Functional Testing 
Among Patients Undergoing Coronary Stenting: 
Insights From the ADORE Trial 
Koon_Hou, Radha Pun, Mark J. Eisenberg, National Heart Centre, Singapore, 
Singapore, Jewish General Hospital, Montreal, Quebec, Canada. 
Background: With increasing number of patients undergoing coronary stenting (CS), the 
role of routine functional testing (FT) is unclear. Our study aims to determine the value of 
this strategy. Mathods: The ADORE Trial randomly assigned 328 patients with success- 
ful coronary angioplasty In 9 countries to selective (clinically ddven) or routine Ff at 6 
weeks, 8 and 9 months after the procedure. Patients were followed-up for adverse clini- 
cal events. The use of invasive and revascluarization procedures were left to the discre- 
tion of the attending physicians. Exercise treadmill testing was performed on all patients 
at 9 months. Resufts: Of 278 (85%) of patients undergoing CS, 148 and 130 of them 
were assigned to the selective and routine groups, respectively. Baseline characteristics 
were similar. Overall, the mean age was 57 years, and 85% of them were male, about a 
sixth had diabetes or prior infarction, and a third had prior angioplasty. Almost 90% of 
patients had single-vessel disease and ~50% had 92/C lesion characteristics. The distri- 
bution of the vessel and number of lesions treated were also similar between the 2 
groups. After a follow-up period of 9 months, the occurrences of adverse events were as 
follows: 
Event Selective Routine 
Death (%) 1 2 
Myocardial Infarction (MI) (%) 2 2 
Unstable angina (UA) (%) 8 10 
Repeat angiography (%) 12 14 
Revascularization (%) 8 12 
Composite (death/UAIMI) (%) 7 6 
Exercise capacity was marginally lower in the selective group (9.4 vs 10.2 METS; 
P=O.O84). Conclusion: Routine FT did not prevent adverse clinical events among 
patients undergoing coronary stenting. 
1078-12 Smoking and Restenosis After Coronary Artery 
Stenting: The Artifact of Smoker’s Paradox 
Julinda, Adnan Kastrati. Josef Dirschinger, Jfirgen Pache, Helmut SchShlen. 
Heidrun Holle, Franz Dotzer, Franz-Josef Neumann, Albert Schomig, Deutsches 
Herzzentrum, Munich, Germany, 1. Med. Klinik rechts der tsar, Munich, Germany 
Background: Cigarette smoking is a strong risk factor for heart disease. Some previous 
studies showed a lower incidence of adverse events and restenosis after percutaneous 
coronary interventions (PCI) in smokers which has since been called the ‘smoker’s para- 
dox’. We investigated the influence of smoking on restenosis after stenting. 
Methods: A consecutive series of 6911 patients who underwent coronary artery stenting 
was analyzed. The follow-up protocol included 8-month angiography (performed in 80% 
of the patients) and a contact 12 months after the procedure. Primary endpoint of the 
study was angiographic restenosis defined as a 2 50% diameter stenosis at follow-up. 
Other endpoints were the combined rate of death or myocardial infarction and the need 
for reinterventions at 1 year. 
Resufts: As shown in the table, the risk profile of the smokers is significantly different 
from that of nonsmokers. Apparently, smokers have a lower risk for restenosis. However, 
the risk reduction disappears after adjustment for baseline characteristics: adjusted odds 
ratio, 0.94 [95% Cl, 0.81-1.091. More importantly, smokers showed a significantly 
increased risk of death or myocardial infarction (adjusted hazard ratio, 1.29 [95% Cl, 
1.03.1.81]). 
Conchtalons: The apparent relation between smoking and a lower restenosis rate after 
PCI is the consequence of more favorable baseline characteristics. Smoking itself has an 
unfavorable influence on the outcome after stenting by increasing the risk of the most 
dreadful events. 
Unlvariate analysis 
Age. yrs 
Women, % 
Diabetes, % 
Multivessel disease, % 
Vessel size, mm 
Angiographic restenosis. % 
Reinterventions, % 
Death or MI, % 
Smokers (n=1848) Nonsmokers (n=5083) 
59tll 67*10 <O.OOl 
18 27 <O.OOl 
15 22 <O.OOl 
67 75 <O.OOl 
3.08*0.51 3.00*0.54 <O.OOl 
28 31 0.04 
17 19 0.13 
8.4 6.9 0.54 
1078-13 Is Direct Stenting an Effective Therapy for Long-Term 
Outcome? Results of the Randomized Bet Study 
&drer Carrie, Khalife Khalife, Bernard Citron, Kari Isaaz, Martial Hamon, Jean M Juliard, 
Elyes El Mokhtar, Jean P Rinaldi, Joelle Fourcade, Remi Sabatier, for the Bet SrUdy 
Group, Toulouse, France. 
Background : The BET (Benefit Evaluation of Direct Coronary Stenting) study is multi- 
venter randomized trial comparing direct (without balloon predilatation) versus conven- 
tional stent implantation (Tenax. Biotronik inc.) to evaluate immediate and long-term 
outomes. 
We have demonstrated that Direct Stenting (DS=) is feasiblesafe, with reduction of pro- 
cedural cost and similar in-hospital clinical outcome. Long-term outcome is unknown and 
no comparison exists with conventional stenting (DS-). 
Methods : 328 randomized patients had a mean clinical follow-up of 16.4 + 4.8 months 
(3.1 - 23.7) which allows to evaluate ma]or adverse cardiac events (MACE) and target 
lesion revascularization (TLR) rates. 
DS (-) DS (+) 
n=181 n=187 
MACE TLR MACE TLR 
3 Months 1.9% 1.2% 1.2 % 0.8 % 
8 Months 5.1 % 3.2 % ns 5.4 % 3.7 % 
12 Months 9.1 % 5.2 % 10.8 % 7% 
More than 18 months 11.3% 5.2 % 18.2 % 7% 
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Multivariate analysis demonstrated that P-year MACE rate was related to post-procedural 
minimal lumen diameter < 2.46 mm (p = 0.013), previous myocardial infarction (p = 
0.0206), stent diameter of 3 mm (p = 0.0325) and hypertension (p = 0.0422). 
Conclusion : In comparison with DS-, these results show that DS+ has a similar rate of 
cardiac events at long-term follow-up and don’t reduce the incidence late restenosis. 
1078-14 Stents Covered by Autoiogoue Venous Grafts in Human 
Coronary Arteries: Five-year Follow-up 
mToutouzas, Christodoulos Stefanadis. Eleftherios Tsiamis, Sophia Vaina, 
loannis Kallikazaros, Manolis Vavouranakis, Kostas Tsioufis, Dimitrios Tousoulis, Pavlos 
Toutouzas, Htppokration Hospital, Athens, Greece. 
Background: The mid-term results after the implantation of autologous venous-graft 
covered stents (AVGCS) in human coronary arteries were favorable. The aim of our 
study was to present the long-term results of this technique. Morover, a comparison was 
performed with the long-term results of uncovered stents. Methods: A venous graft was 
removed from an upper limb. Conventional stents then were covered either both inter- 
nally and externally, or only externally by autologous venous grafts. Fifty-eight AVGCS 
were implanted in 56 patients, including 16 patients with acute coronary syndromes 
(ACS). Additionally, in the control group we enrolled 114 patients, in whom 136 uncov- 
ered stents were implanted including 36 patients with ACS. The demographic character- 
istics of the two groups were similar. Results: The procedure was successful in all 
patients. Acute thrombosis was observed in 3 patients of the control group. One patient 
with an AVGCS pressnted with subacute thrombosis. The restsnosis rate was 13.3% in 
covered stents vs 20.6% (p=NS). All patients were examined clinically or interviewed by 
telephone communication at a mean of 62.4 * 14.5 months in AVGCS group and 65.3 f 
12.7 months in the control group. The minimal lumen diameter had a trend to be greater 
in the AVGCS group at follow-up (2.22 f 0.9 vs 2.10 * 0.9 mm, p=O.O7). The target ves- 
sel revascularization rate was 14% in the AVGCS group vs 17.1% in the control group 
(p=NS). The event-free sumival rate at 4 years was 62% in the AVGCS YS 79% in the 
control group (p=NS). The event-free survival rate in ACS was 92% in AVGCS versus 
75% in the control group, respectively (P = 0.06). Stents covered by thicker venous grafts 
were associated with improved clinical outcome. Conclusions: Stents covered by autol- 
ogous venous grafts may be safely prepared without complications. The long-term 
results after AVGCS implantation showed that covered stems by venous grafts are not 
associated with late complications, which are related to the technique. 
1078-15 Randomized Comparison of Gold-Coated NIA Stents 
With Uncoated NIR Stents in Patients With Coronary 
Artery Disease 
Seung-Jung Park, Seong-Wook Park, Jae-Joong Kim, Myeong-Ki Hong, Cheol Whan 
Lee, Seung-Jea Tahk, Yang Soo Jang, Ki Bae Seung. Myung Ho Jeong, Joo-Youna 
m, Asan Medical Center, University of &an, Seoul, South Korea, Ajou University 
Hospital, Suwon, South Korea. 
Background: Gold coatings enhance the radiopacity 01 steel stems, facilitating stem 
deployment into the target lesion. However, it remains uncertain whether gold coatings 
are a risk factor for restenosis after coronary stenting. The aim of this study was to deter- 
mine whether gold-coatings increase the risk of in-stent restenosis in patients with coro- 
nary artery disease. 
Methods: Two hundred and ten patients with 210 lesions (diameter stenosis > 50%. 
lesion length 2.5 mm) were randomly assigned to receive either an uncoated NIR stem 
group (Group I, n=105) or a gold-coated NIR stent group (Group II, n=105). The primary 
end point was angiographic restenosis at 6 months follow-up. and the secondary end 
point was major adverse cardiac events during 9 months. 
Results: The baseline characteristics were similar between the two groups. Procedural 
success rate was 99.0% in group I and 100% in group II. In-hospital events did not occur 
in any patients. Angiographic follow-up were obtained in 169 patients (61.3% of those eli- 
gible), and the rates of angiographic restenosis were 27.1% in group I, and 44.0% in 
group II (~~0.05). Acute gain was not different between the two groups. However, late 
loss and loss index were significantly higher in group II than in group I (PcO.05). There 
was a trend of a higher incidence of major adverse cardiac events in group I than in 
group II (16.2% vs 26.7%, respectively, p=O.O6). 
Conclusion: Gold coatings may increase the risk of restenosis after coronary stenting. 
1078-16 The Morphological and Histological Findings of 
Reetenoeis After Self-Expanding Biodegradable 
Coronary Stent impiantation 
Takafumi, Hideo Tamai, Keiji Igaki, Eisho Kyo. Kunihiko Kosuga, Tatsuhiko Hata, 
Masaharu Okada. Takuji Nakamura, Sinya Fujita, Sinsaku Takeda, Seiichiro Motohara, 
Hiromu Uehata, Shiga Medical Center For Adults, Moriyama, Japan, lgaki Medical 
Planning Co. Ltd., Kyoto, Japan. 
Background: We have repotted the low restenosis rate of Igaki-Tamai biodegradable self- 
expanding Stent within 6 months in the human coronary arteries. We analyzed the mor- 
phology and histology of in-stent restenosis 01 the stent and initial outcomes of target 
lesion revascularization (TLR). Method: Sixty-three lesions in 50 patients underwent 
poly-L-lactic acid (PLLA) stem implantation for coronary artery stsnosis. Eleven lesions 
(17.5%) in 10 patients revealed restenosis (%diameter stenosis > 50% at follow-up) and 
6 lesions in 5 patients received TLA within 6 months. We assessed an angiographic clas- 
sification of in-stent rsstenosis according to the geographic distribution of intimal hyper- 
plasia. Removed tissues of restenosis by dirsctlonal coronary atherectomy (DCA) were 
histologically examined by light-microscope and electron-microscope. Results: The refer- 
ence vessel diameter of 11 restenotic lesions before stent implantation was 2.97t0.49 
mm and the lesion length was 12.2~4.5 mm by quantitative coronary angiography. The 
morphology of 11 in-stem restenosis were 2 focal body, 4 focal margin, 2 diffuse intras- 
tent, 2 diffuse proliferative and 1 total occlusion. One focal marginal, 1 diffuse intrastent, 
1 diiuse proliferative and 1 total occluded in-stem restsnosis received repeat balloon 
angioplasty. One focal marginal and 1 diffuse intrastent in-stent restenosis received 
repeat angioplasty by DCA. The in-stem restenosis were easily dilated by balloon angio- 
plasty and easily excised by DCA. The stent struts were also easily excised by DCA. No 
major cardiac events such as death, myocardial infarction or bypass surgery associated 
with repeat angioplasty developed within the follow-up period. The histological findings 
revealed that there were proliferation of fibroblastic cells with myxoid stromal component 
partially surrounding the stem materials and no evidence of thrombogenesis nor foreign 
body response. Conclusions: Repeat angioplasty for in-stent restenosis of Igaki-Tamai 
stent performed easily and safely. The morphology of in-stem restenosis was similar to 
that of metallic stents and histological findings suggest biocompatibility of PLLA stent. 
1078-17 Causes of Death in Patients With in-Sent Reetenoeie 
mFarb, Breno S. Pessanha, Allen P. Burke. Renu Virmani, Armed f%ces institute 
of Pathology, Washington, Dist. of Columbia. 
Background: Stenting is standard treatment for coronary revascularization. and stems 
generally perform favorably with respect to patient survival. However, there have been no 
data reported on the causes of death with autopsy confirmation in patients with initially 
successful coronary stenting. 
Methods: From an ongoing registry study of human coronary artery stents submitted for 
pathologic analysis, patients with coronary stents deployed >3 months antemortem were 
identified. Clinical history and autopsy findings were reviewed. Stems and coronary arter- 
ies underwent detailed histologic evaluation. 
Results: The study group consisted of 67 patients (42 men, 25 women; age 59f13 
years) with coronary stenting performed a mean of 10 months antemortem. Coronary 
death (CD) accounted for 50167 (75%) cases and non-CD was responsible for the 
remaining 17 (25%). In-stent restenosis (ISR) was present in 50 cases: 43/50 (66%) with 
CD and 7117 (41%) with non-CD (p<O.OOl). Of the 50 ISR patients, death was associated 
with: (1) ISR alone, without severe atherosclerosis in other major coronary arteries, in 17 
cases (34%): (2) ISR with severe atherosclerosis in >l additional non-stented coronaty 
artery in 23 cases (46%); and (3) complications following repeat revascularizatfon (cathe- 
ter-based or CABG) in 10 cases (20%), all with severs atherosclerosis in 21 additional 
non-stented coronary artery. Of patients with ISR, 35% were symptomatic prior to death 
or attempted revascularization. Acute thrombosis of non-stented coronary arteries was 
present in 5 patients, and late stent thrombosis was seen in an additional 5 cases (3 of 
which with associated ISR). Notably, 32 of the 50 cases of CD after stenting were sudden 
and unexpected (64%). 
Conclusions: In patients dying after successful coronary stenting, >75% have ISR, of 
which a majority have multi-vessel coronary atherosclerosis involving non-stented arter- 
ies. Sudden coronary death is common. The data support long-term follow-up of patients 
with coronary stsnts to identity in-stem restenosis and progressive atherosclerosis to pre- 
vent late cardiac death. 
1078-18 Local Delivery of Evans Blue Significantly Prevents in- 
Stent Restenoeie in Patients With Acute Myocardial 
infarction 
sFullmori. Hiroshi Mario, Kuniko Terasawa, Takashi Shiga, Masaru Hatano, 
Masaaki Osegawa, Yasumi Uchida, Toshihiro Morita, Narita Red Cross Hospital, Narita, 
Japan, University of Tokyo, Tokyo, Japan. 
Background Restenosis remains to be solved in coronary intervention. Especially, in- 
Stent restenosis occurs more frequently in patients with acute myocardial infarction (AMI) 
than in those with angina pectoris. We evaluated the effect of local delivery of Evans blue 
dye on prevention of restenosis in patients with AMI. 
Methods Eighty-one patients with AMI. who were treated with primary stent, were ran- 
domized to two groups. In 41 patients, including 33 males and 6 females (59.0+6.6 years 
old, mean f SD), we administered 1 ml of 2% Evans blue dye (20mg) by local delivety 
technique, using porous balloon catheter 3 weeks after the onset (Evans blue group). 
Residual 40 patients (34 males and 6 females, 61.4*9.5 years old), consisted a control 
group without administration of Evans blue dye. Rsstenosis was defined as diameter 
stenosis more than 50% on coronary angiography (CAG) at 7-month follow-up. 
Results Stents used were Multi-Link and GFX stsnts in both groups, and there were no 
differences in lesion distribution, stem diameter, length, and ratio of both stents between 
two groups. Just after stem implantation, there were no differences between two groups 
in reference luminal diameter (3.26+0.39mm vs. 3.19t 0.33mm, Evans blue group vs. 
control group), minimal luminal diameter (3.20+0.31mm vs. 3.07a0.39mm). and diameter 
stenosis (2.3t6.1% vs. 3.2*10.6%). All patients completed follow up CAG (mean, 7 
months). At follow up CAG, reference luminal diameter was not different between Evans 
blue and control group (3.14*0.43mm vs. 3.15+0.32mm, ns). Minimal luminal diameter 
was significantly larger in Evans blue group (2.64&79mm vs. 1.91&.76mm. p<O.o005). 
Diameter stenosis was significantly lower in Evans blue group (17.2*19.1% vs. 
39.5&3.6%, pcO.0005). Restenosis rate was also significantly lower in Evans blue group 
(5% vs. 25%, p<O.O5). 
Conclusion Local delivery of Evans blue dye significantly prevented in-stsnt intimal pro- 
liferation and rsstenosis in patients with AMI. 
